{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:47:16Z","timestamp":1761198436530,"version":"3.40.3"},"reference-count":82,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2025.12835","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T12:45:01Z","timestamp":1740487501000},"page":"1-11","source":"Crossref","is-referenced-by-count":4,"title":["Preliminary results and a theoretical perspective of co\u2011treatment using a miR\u201193\u20115p mimic and aged garlic extract to inhibit the expression of the pro\u2011inflammatory interleukin\u20118 gene"],"prefix":"10.3892","volume":"29","author":[{"given":"Roberto","family":"Gambari","sequence":"first","affiliation":[{"name":"Department of Life Sciences and Biotechnology, University of Ferrara, I\u201144121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Papi","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Biotechnology, University of Ferrara, I\u201144121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Gasparello","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Biotechnology, University of Ferrara, I\u201144121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Agostinelli","sequence":"additional","affiliation":[{"name":"Department of Sensory Organs, Sapienza University of Rome, Policlinico Umberto I, I\u201100161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Finotti","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Biotechnology, University of Ferrara, I\u201144121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"key20250401110545_b1-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3201\/eid2602.190697","article-title":"Middle east respiratory syndrome coronavirus transmission","volume":"26","author":"Killerby","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"key20250401110545_b2-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41581-022-00642-4","article-title":"Therapeutic advances in COVID-19","volume":"19","author":"Murakami","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"key20250401110545_b3-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41431-023-01462-1","article-title":"A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: Host extracellular to systemic effects of SARS-CoV-2 infection","volume":"32","author":"Narayanan","year":"2024","journal-title":"Eur J Hum Genet"},{"issue":"1751","key":"key20250401110545_b4-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10101751","article-title":"Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and vaccine effectiveness","volume":"10","author":"Tulimilli","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"key20250401110545_b5-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: A mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"key20250401110545_b6-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.abc0035","article-title":"The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries","volume":"369","author":"Walker","year":"2020","journal-title":"Science"},{"issue":"596587","key":"key20250401110545_b7-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.596587","article-title":"The need for antiviral drugs for pandemic coronaviruses from a global health perspective","volume":"7","author":"Villamagna","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"key20250401110545_b8-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/cid\/ciad181","article-title":"Triple combination therapy with 2 antivirals and monoclonal antibodies for persistent or relapsed severe acute respiratory syndrome coronavirus 2 infection in immunocompromised patients","volume":"77","author":"Mikulska","year":"2023","journal-title":"Clin Infect Dis"},{"key":"key20250401110545_b9-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/cid\/ciad685","article-title":"Review: The landscape of antiviral therapy for COVID-19 in the era of widespread population immunity and omicron-lineage viruses","volume":"78","author":"Meyerowitz","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4896","key":"key20250401110545_b10-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164896","article-title":"COVID-19-related ARDS: Key mechanistic features and treatments","volume":"11","author":"Selickman","year":"2022","journal-title":"J Clin Med"},{"issue":"553","key":"key20250401110545_b11-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3390\/v15020553","article-title":"Hyperinflammatory response in COVID-19: A systematic review","volume":"15","author":"Silva","year":"2023","journal-title":"Viruses"},{"key":"key20250401110545_b12-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.23812\/20-1-E","article-title":"Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: A promising inhibitory strategy","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"666223","key":"key20250401110545_b13-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666223","article-title":"Profile of circulatory cytokines and chemokines in human coronaviruses: A systematic review and meta-analysis","volume":"12","author":"Zawawi","year":"2021","journal-title":"Front Immunol"},{"key":"key20250401110545_b14-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","article-title":"The immunology of long COVID","volume":"23","author":"Altmann","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"key20250401110545_b15-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1089\/vim.2024.0025","article-title":"Cytokine profile in patients with postacute sequelae of COVID-19","volume":"37","author":"Ghorra","year":"2024","journal-title":"Viral Immunol"},{"key":"key20250401110545_b16-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin Chim Acta"},{"key":"key20250401110545_b17-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"issue":"112419","key":"key20250401110545_b18-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112419","article-title":"Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications","volume":"145","author":"Majidpoor","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"613422","key":"key20250401110545_b19-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front Immunol"},{"issue":"795315","key":"key20250401110545_b20-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.795315","article-title":"Immunotherapy of COVID-19: Inside and beyond IL-6 signalling","volume":"13","author":"Zizzo","year":"2022","journal-title":"Front Immunol"},{"issue":"602395","key":"key20250401110545_b21-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.602395","article-title":"Interleukin-8 as a biomarker for disease prognosis of coronavirus disease-2019 patients","volume":"11","author":"Li","year":"2021","journal-title":"Front Immunol"},{"issue":"14","key":"key20250401110545_b22-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3390\/medicines11070014","article-title":"Cytokine storm in COVID-19: Insight into pathological mechanisms and therapeutic benefits of chinese herbal medicines","volume":"11","author":"Yu","year":"2024","journal-title":"Medicines (Basel)"},{"issue":"100190","key":"key20250401110545_b23-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2023.100190","article-title":"COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection","volume":"6","author":"Comarmond","year":"2023","journal-title":"J Transl Autoimmun"},{"issue":"CD013881","key":"key20250401110545_b24-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013881","article-title":"Interleukin-6 blocking agents for treating COVID-19: A living systematic review","volume":"3","author":"Ghosn","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"key20250401110545_b25-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/joim.13231","article-title":"Tocilizumab in COVID-19 interstitial pneumonia","volume":"289","author":"Pomponio","year":"2021","journal-title":"J Intern Med"},{"issue":"e23582","key":"key20250401110545_b26-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023582","article-title":"Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience","volume":"100","author":"Castelnovo","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"key20250401110545_b27-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jinf.2021.03.008","article-title":"IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression","volume":"82","author":"Tharmarajah","year":"2021","journal-title":"J Infect"},{"issue":"e0280677","key":"key20250401110545_b28-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280677","article-title":"Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome","volume":"18","author":"Seg\u00fa-Verg\u00e9s","year":"2023","journal-title":"PLoS One"},{"issue":"e9496","key":"key20250401110545_b29-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94296","article-title":"Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer","volume":"2","author":"Dominguez","year":"2017","journal-title":"JCI Insight"},{"key":"key20250401110545_b30-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s40121-023-00871-5","article-title":"Efficacy and safety of reparixin in patients with severe COVID-19 pneumonia: A phase 3, randomized, double-blind placebo-controlled study","volume":"12","author":"Piemonti","year":"2023","journal-title":"Infect Dis Ther"},{"key":"key20250401110545_b31-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/bjp.2008.270","article-title":"Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice","volume":"155","author":"Zarbock","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"e150862","key":"key20250401110545_b32-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150862","article-title":"Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19","volume":"6","author":"Kaiser","year":"2021","journal-title":"JCI Insight"},{"key":"key20250401110545_b33-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: Biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat Rev Genet"},{"key":"key20250401110545_b34-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/cvr\/cvn151","article-title":"MicroRNA: Basic mechanisms and transcriptional regulatory networks for cell fate determination","volume":"79","author":"Fazi","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"a008144","key":"key20250401110545_b35-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008144","article-title":"microRNAs as developmental regulators","volume":"7","author":"Ivey","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20250401110545_b36-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/dna.2006.0549","article-title":"MicroRNA detection and target prediction: Integration of computational and experimental approaches","volume":"26","author":"Chaudhuri","year":"2007","journal-title":"DNA Cell Biol"},{"key":"key20250401110545_b37-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1101\/gad.1184404","article-title":"Specificity of microRNA target selection in translational repression","volume":"18","author":"Doench","year":"2004","journal-title":"Genes Dev"},{"issue":"110415","key":"key20250401110545_b38-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110415","article-title":"Tackling the COVID-19 \u2018cytokine storm\u2019 with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs","volume":"146","author":"Gasparello","year":"2021","journal-title":"Med Hypotheses"},{"key":"key20250401110545_b39-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1165\/rcmb.2013-0160OC","article-title":"Expression of microRNA-93 and interleukin-8 during pseudomonas aeruginosa-mediated induction of proinflammatory responses","volume":"50","author":"Fabbri","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"108201","key":"key20250401110545_b40-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108201","article-title":"In vitro induction of interleukin-8 by SARS-CoV-2 spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR","volume":"101","author":"Gasparello","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"546","key":"key20250401110545_b41-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00546","article-title":"MicroRNA roles in the nuclear factor kappa B signaling pathway in cancer","volume":"9","author":"Wu","year":"2018","journal-title":"Front Immunol"},{"issue":"478","key":"key20250401110545_b42-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front Genet"},{"issue":"3097","key":"key20250401110545_b43-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113097","article-title":"The challenges and opportunities in the development of MicroRNA therapeutics: A multidisciplinary viewpoint","volume":"10","author":"Momin","year":"2021","journal-title":"Cells"},{"key":"key20250401110545_b44-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: From cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet"},{"key":"key20250401110545_b45-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"4148","key":"key20250401110545_b46-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11918-y","article-title":"Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"key":"key20250401110545_b47-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2217\/epi-2016-0035","article-title":"Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer","volume":"8","author":"Reid","year":"2016","journal-title":"Epigenomics"},{"issue":"113853","key":"key20250401110545_b48-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113853","article-title":"The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells","volume":"433","author":"Zurlo","year":"2023","journal-title":"Exp Cell Res"},{"issue":"104128","key":"key20250401110545_b49-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2023.11.002","article-title":"Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with \u03b2-thalassemia","volume":"129","author":"Cosenza","year":"2024","journal-title":"Exp Hematol"},{"issue":"153583","key":"key20250401110545_b50-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153583","article-title":"Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 spike protein","volume":"87","author":"Gasparello","year":"2021","journal-title":"Phytomedicine"},{"key":"key20250401110545_b51-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"issue":"127","key":"key20250401110545_b52-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00391-8","article-title":"Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines","volume":"6","author":"Sartorius","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"945","key":"key20250401110545_b53-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13070945","article-title":"Intracellular routing and recognition of lipid-based mRNA nanoparticles","volume":"13","author":"Delehedde","year":"2021","journal-title":"Pharmaceutics"},{"key":"key20250401110545_b54-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jcf.2008.06.002","article-title":"Anti-inflammatory effect of miglustat in bronchial epithelial cells","volume":"7","author":"Dechecchi","year":"2008","journal-title":"J Cyst Fibros"},{"key":"key20250401110545_b55-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.intimp.2012.04.010","article-title":"Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells","volume":"13","author":"Gambari","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"key20250401110545_b56-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jgm.1546","article-title":"Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-\u03baB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells","volume":"13","author":"De Stefano","year":"2011","journal-title":"J Gene Med"},{"key":"key20250401110545_b57-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3892\/ijmm.2020.4610","article-title":"MicroRNA-93 contributes to the suppression of lung inflammatory responses in LPS-induced acute lung injury in mice via the TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"46","author":"Gao","year":"2020","journal-title":"Int J Mol Med"},{"issue":"167155","key":"key20250401110545_b58-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167155","article-title":"Toll like receptor 4 mediates the inhibitory effect of SARS-CoV-2 spike protein on proximal tubule albumin endocytosis","volume":"1870","author":"Silva-Aguiar","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"100347","key":"key20250401110545_b59-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgeb.2023.100347","article-title":"SARS-CoV-2 omicron spike shows strong binding affinity and favourable interaction landscape with the TLR4\/MD2 compared to other variants","volume":"22","author":"Chakraborty","year":"2024","journal-title":"J Genet Eng Biotechnol"},{"issue":"112189","key":"key20250401110545_b60-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112189","article-title":"SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice","volume":"42","author":"Fontes-Dantas","year":"2023","journal-title":"Cell Rep"},{"key":"key20250401110545_b61-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs","volume":"92","author":"Choudhury","year":"2020","journal-title":"J Med Virol"},{"key":"key20250401110545_b62-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res"},{"key":"key20250401110545_b63-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jmv.26387","article-title":"Targeting human TLRs to combat COVID-19: A solution?","volume":"93","author":"Patra","year":"2021","journal-title":"J Med Virol"},{"key":"key20250401110545_b64-ETM-29-4-12835","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1570180818666210901125519","article-title":"In silico identification of new anti-SARS-CoV-2 agents from bioactive phytocompounds targeting the viral spike glycoprotein and human TLR4","volume":"19","author":"Das","year":"2022","journal-title":"Lettr Drug Des Discov"},{"issue":"e21893","key":"key20250401110545_b65-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21893","article-title":"SARS-CoV-2 activates the TLR4\/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19","volume":"9","author":"Sahanic","year":"2023","journal-title":"Heliyon"},{"issue":"293","key":"key20250401110545_b66-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01584-x","article-title":"Inhibition of Toll-like receptor 4 and Interleukin-1 receptor prevent SARS-CoV-2 mediated kidney injury","volume":"9","author":"Nakazawa","year":"2023","journal-title":"Cell Death Discov"},{"key":"key20250401110545_b67-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.2147\/JIR.S474707","article-title":"Interplay of TLR4 and SARS-CoV-2: Unveiling the complex mechanisms of inflammation and severity in COVID-19 infections","volume":"17","author":"Asaba","year":"2024","journal-title":"J Inflamm Res"},{"issue":"5938","key":"key20250401110545_b68-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29245938","article-title":"Aged garlic extract (AGE) and its constituents S-allyl-cysteine (SAC) inhibit the expression of pro-inflammatory genes induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 spike protein and the BNT162b2 vaccine","volume":"29","author":"Gasparello","year":"2024","journal-title":"Molecules"},{"issue":"76","key":"key20250401110545_b69-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2023.5279","article-title":"Effects of Sulforaphane on SARS-CoV-2 infection and NF-\u03baB dependent expression of genes involved in the COVID-19 \u2018cytokine storm\u2019","volume":"52","author":"Gasparello","year":"2023","journal-title":"Int J Mol Med"},{"issue":"1538","key":"key20250401110545_b70-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071538","article-title":"Vaccine mRNA can be detected in blood at 15 days post-vaccination","volume":"10","author":"Fertig","year":"2022","journal-title":"Biomedicines"},{"key":"key20250401110545_b71-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41440-023-01460-2","article-title":"The role of SARS-CoV-2-mediated NF-\u03baB activation in COVID-19 patients","volume":"47","author":"Zhou","year":"2024","journal-title":"Hypertens Res"},{"issue":"1996","key":"key20250401110545_b72-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10101996","article-title":"The SARS-CoV-2 S1 spike protein promotes MAPK and NF-\u03baB activation in human lung cells and inflammatory cytokine production in human lung and intestinal epithelial cells","volume":"10","author":"Forsyth","year":"2022","journal-title":"Microorganisms"},{"key":"key20250401110545_b73-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1172\/JCI11837","article-title":"Toll-like receptor-mediated NF-kappaB activation: A phylogenetically conserved paradigm in innate immunity","volume":"107","author":"Zhang","year":"2001","journal-title":"J Clin Invest"},{"key":"key20250401110545_b74-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/acel.12322","article-title":"Relation between TLR4\/NF-\u03baB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability","volume":"14","author":"Gargiulo","year":"2015","journal-title":"Aging Cell"},{"key":"key20250401110545_b75-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1165\/rcmb.2003-0329OC","article-title":"Toll-like receptors in normal and cystic fibrosis airway epithelial cells","volume":"30","author":"Muir","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key20250401110545_b76-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.4049\/jimmunol.174.3.1638","article-title":"TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells","volume":"174","author":"Greene","year":"2005","journal-title":"J Immunol"},{"key":"key20250401110545_b77-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.febslet.2014.03.013","article-title":"MicroRNA-93 inhibits inflammatory cytokine production in LPS-stimulated murine macrophages by targeting IRAK4","volume":"588","author":"Xu","year":"2014","journal-title":"FEBS Lett"},{"key":"key20250401110545_b78-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3892\/etm.2017.4874","article-title":"MicroRNA-93 inhibits inflammatory responses and cell apoptosis after cerebral ischemia reperfusion by targeting interleukin-1 receptor-associated kinase 4","volume":"14","author":"Tian","year":"2017","journal-title":"Exp Ther Med"},{"issue":"1376","key":"key20250401110545_b79-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-6109","article-title":"M2 macrophage-derived exosomal miR-145-5p protects against the hypoxia\/reoxygenation-induced pyroptosis of cardiomyocytes by inhibiting TLR4 expression","volume":"10","author":"Wei","year":"2022","journal-title":"Ann Transl Med"},{"key":"key20250401110545_b80-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"11115","DOI":"10.1002\/jcb.28388","article-title":"miR-145-5p inhibits tumor occurrence and metastasis through the NF-\u03baB signaling pathway by targeting TLR4 in malignant melanoma","volume":"120","author":"Jin","year":"2019","journal-title":"J Cell Biochem"},{"key":"key20250401110545_b81-ETM-29-4-12835","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jmcb\/mjr007","article-title":"MicroRNAs in NF-kappaB signaling","volume":"3","author":"Ma","year":"2011","journal-title":"J Mol Cell Biol"},{"issue":"111519","key":"key20250401110545_b82-ETM-29-4-12835","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111519","article-title":". The interaction between miRNAs\/lncRNAs and nuclear factor-\u03baB (NF-\u03baB) in human disorders","volume":"138","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed Pharmacother"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T09:02:40Z","timestamp":1743498160000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2025.12835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":82,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2,25]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2025.12835","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"type":"print","value":"1792-0981"},{"type":"electronic","value":"1792-1015"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}